Left ventricular diastolic dysfunction in asymptomatic type 2 diabetes mellitus patients

Karan Jain, Amit A. Palange, Arjun Lal Kakrani, Akshay S. Dhanorkar


Background: Diastolic dysfunction has been described as an early sign of diabetic heart muscle disease preceding the systolic damage. The pathogenesis of ventricular dysfunction remains unknown and has been somewhat controversial. So far, very few population-based studies have been carried out in India, to demonstrate the prevalence of diastolic dysfunction in diabetic subjects. Hence the present study was done at our tertiary care centre to detect left diastolic dysfunction in asymptomatic type 2 diabetes individuals and to use echo-cardiologic assessment as an early detector of left diastolic dysfunction. The aim of this study was to detect left diastolic dysfunction in asymptomatic type 2 diabetes individuals and to use echocardiologic assessment as an early detector of left diastolic dysfunction.

Methods: A hospital based cross-sectional observational study was conducted with 50 patients for echocardiographic evaluation of diastolic dysfunction in asymptomatic Type 2 Diabetes Mellitus. E/A <1 and increase in LA size was considered as the evidence of left ventricular Diastolic Dysfunction.

Results: 15 (30%) patients were detected with Left Ventricular Diastolic Dysfunction (LVDD) among the 50 patients under study.

Conclusions: Diastolic dysfunction in patients with diabetes is present in 30% of patients even when diabetes is present at a younger age, and is of a shorter duration. This dysfunction is suggestive of pre-clinical diabetic cardiomyopathy. E/A, DT and peak A velocity are sensitive indices of diastolic LV dysfunction. Thus, diastolic dysfunction can be used as an early indicator, as it is a precursor to increased LV hypertrophy and clinical left ventricular dysfunction.


Diabetes mellitus, Diastolic dysfunction, Echocardiography, E/A ratio, LA size

Full Text:



World Health Organisation. Addressing health inequalities in Indonesia, 2017. Available at

Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endo Metab. 1999;84:2329-35.

Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Current Science. 2002:1483-96.

Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia. 1986;29(4):235-7.

Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up study. Diabetes. 1974;23(2):105-11.

Weiner DA, Ryan TJ, McCabe CH, Luk S, Chaitman BR, Sheffield LT, Tristani F, Fisher LD. Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. Am J Cardiol. 1987;59(8):725-9.

Airaksiran K E J. Silent coronary artery disease in diabetics-A feature of autonomic neuropathy or accelerated atherosclerosis. Diabetologia. 2001;44:256-66.

From AM, Scott CG, Chen HH. Changes in diastolic dysfunction in diabetes mellitus over time. Am J Cardiol. 2009;103:1463-6.

Van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, et al. Diastolic stiffness of the failing diabetic heart. Circulation. 2008;117(1):43-51.

Oh JK, Seward JB, Tajik AJ. Assessment of diastolic dysfunction and diastolic heart failure. In: Oh JK, editor. The Echo Manual. 34th ed. New Delhi:Wolters Kluwer;2006:120-41.

Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J. 1989;118:1000-12.

Francis GS. Diabetic cardiomyopathy: fact or fiction? Heart. 2001;85:247-8.

Sharavanan TKV, Prasanna KB, Ekanthalingam S, Sundaram A, Premalatha E, Arumugam B. A study on the prevalence of diastolic dysfunction in type 2 diabetes mellitus in a tertiary care hospital. IAIM. 2016;3(7):216-221.

Russo C, Jin Z, Homma S, Rundek T, Elkind MS, Sacco RL, et al. Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol. 2011;57:1368-74.

Dikshit NM, Wadia PZ, Shukla DK. Diastolic Dysfunction in Diabetes Mellitus. National Journal of Medical Research. 2013;3(3).

Senthil N, Vengadakrishnan K, Vankineni SS, Sujatha S. Diastolic Dysfunction in Young Asymptomatic Diabetics Patients. Int J Sci Stud. 2015;3(7):226-229.

Raev DC. Which LV function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care. 1994;17:633-9.

Chaudhary AK, Aneja GK, Shukla S, Razi SM. Study on Diastolic Dysfunction in Newly Diagnosed Type 2 Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin (HbA1C). J Clinic Diagnostic Res. 2015;9(8):OC20-OC22.

Patil VC, Patil HV, Shah KB, Vasani JD, Shetty P. Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function. J Cardiovasc Dis Res. 2011;2(4):213-22.

Ashraf SM, Basir F. Association of hypertension and diastolic dysfunction with type 2 diabetes mellitus. Pak J Medic Sci. 2007;23:344-8.

Patil MB, Burji NP: Echocardiographic evaluation of diastolic dysfunction in asymptomatic type 2 diabetes mellitus. J Assoc Physic Ind. 2012;60:23-6.

Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974;34:29-34.

Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358-67.

Cosson S, Kevorkian JP. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy. Diabetes Metab. 2003;29:455-66.

Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J. 2001;35:166-8.